USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ATRIX LABORATORIES, INC.
Address:
2579 MIDPOINT DR
Fort Collins, CO 80525
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $591,519.00 8
SBIR Phase II $741,290.00 1

Award List:

A BIODEGRADABLE, INJECTABLE DELIVERY SYSTEM FOR NSAIDS

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
HHS
Principal Investigator:
Arthur J Tipton
Abstract:
In this research, nsaids will be individually incorporated into a delivery system. the in vitro delivery rates will bedetermined, and then the system optimized to obtain in vitro delivery rates of 1 to 12 weeks. the variables that will be examined to optimize release are polymer type and molecular… More

N/A

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
HHS
Principal Investigator:
Richard L Dunn
Abstract:
N/a

BIODEGRADABLE INJECTABLE DELIVERY SYSTEM FOR NALTREXONE

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,900.00
Agency:
HHS
Principal Investigator:
Arthur Tipton
Abstract:
Naltrexone is an effective narcotic antagonist. however, its effectiveness is limited by the need for high patient compliance, as oral dosages must be taken at least three times weekly. by using a proprietary delivery system, it isexpected that naltrexone can be delivered at a controlled rate for… More

A BIODEGRADABLE WOUND TREATMENT

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,710.00
Agency:
HHS
Principal Investigator:
Tipton, Arthur J , Principal Investigator
Abstract:
We will develop a biodegradable wound treatment that can be aerosolized directly onto a wound surface. it will form a tough, flexible film that will seal the wound and provide for proper water levels at the wound surface. an antibiotic will be incorporated into the biodegradable polymer and will be… More

DEVELOPMENT OF AN ANTIINFECTIVE GTR BARRIER PRODUCT

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$99,325.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

GUIDED BONE REGENERATION WITH BONE MORPHOGENIC PROTEIN

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$99,781.00
Agency:
HHS
Principal Investigator:
Dunn, richard l
Abstract:
N/a

BONE REPAIR BY OSTEOBLAST TRANSPLANT USING POLYMER FILMS

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$95,600.00
Agency:
HHS
Principal Investigator:
Garrett, J S
Abstract:
N/a

DEVELOPMENT OF AN ANTIINFECTIVE GTR BARRIER PRODUCT

Award Year / Program / Phase:
1998 / SBIR / Phase II
Award Amount:
$741,290.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

INTRATUMORAL TREATMENT OF HEAD AND NECK CANCERS

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$99,203.00
Agency:
HHS
Principal Investigator:
Dunn, Richard L
Abstract:
N/a